首页> 外文期刊>Journal of Ophthalmic Inflammation and Infection >Scedosporium apiospermum endopthalmitis treated early with intravitreous voriconazole results in recovery of vision
【24h】

Scedosporium apiospermum endopthalmitis treated early with intravitreous voriconazole results in recovery of vision

机译:玻璃体腔伏立康唑早期治疗的油菜孢子虫内吞性炎可导致视力恢复

获取原文
       

摘要

The purpose of this study is to report a case of endogenous endopthalmitis caused by Scedosporium apiospermum with a favorable outcome and review previously reported cases, their treatment regimens and outcomes. An 83-year-old man with diabetes mellitus, no other immunocompromising risk factors, and a history of S. apiospermum endopthalmitis in the left eye developed endopthalmitis in the right eye. Within 72?h of presentation, he was treated with a pars plana vitrectomy and intravitreal voriconozole. Vitreous cultures confirmed S. apiospermum. The patient responded to treatment, with a favorable outcome and full recovery of vision. Recognition of S. apiospermum endopthalmitis and appropriate early intervention with pars plana vitrectomy and intravitreal voriconozole can lead to a favorable outcome with restoration of visual acuity.
机译:这项研究的目的是报告一例由油菜假单胞菌引起的内源性眼内炎,并取得令人满意的结果,并回顾先前报道的病例,其治疗方案和结果。一名83岁的糖尿病患者,无其他免疫功能低下的危险因素,并且左眼有无精子链球菌眼内炎的病史,右眼发展为眼内炎。在就诊72小时内,他接受了玻璃体玻璃体切除术和玻璃体内伏立康唑治疗。玻璃体培养证实了apispermum。患者对治疗反应良好,结果良好,视力完全恢复。认识到精子链球菌眼内炎和适当的早期手术治疗,如玻璃体切除术和玻璃体内伏立康唑,可导致视力恢复良好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号